## Abstract The use of mammalian cells as substrates for the production of various vaccines is a timeβhonored procedure. With the advent of recombinant DNA technology, various investigators soon realized that these techniques could be applied to mammalian cells to convert them to reliable, safe pro
β¦ LIBER β¦
Hijacking bacterial glycosylation for the production of glycoconjugates, from vaccines to humanised glycoproteins
β Scribed by Cuccui, Jon; Wren, Brendan
- Book ID
- 126865889
- Publisher
- Pharmaceutical Press
- Year
- 2014
- Tongue
- English
- Weight
- 833 KB
- Volume
- 67
- Category
- Article
- ISSN
- 2042-7158
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
From virus to vaccine: Recombinant mamma
β
Laurence A. Lasky
π
Article
π
1990
π
John Wiley and Sons
π
English
β 337 KB
Differential Use of Alcian Blue and Tolu
β
D.E. Terry; R.K. Chopra; J. Ovenden; T.P. Anastassiades
π
Article
π
2000
π
Elsevier Science
π
English
β 131 KB
Alcian blue and toluidine blue dyes form complexes with anionic glycoconjugates (AG) such as proteoglycans (PG) and glycosaminoglycans (GAG). However, the Alcian blue-AG complexes do not readily dissociate, while the toluidine blue-AG complexes do so in salt solutions. This differential dissociation
Preparation of a monoclonal antibody to
π
Article
π
1990
π
Elsevier Science
π
English
β 189 KB